Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by WHATTHE1on Oct 19, 2020 2:14pm
187 Views
Post# 31742094

Who’s Who

Who’s Who"A top company getting a lot of attention on the Healthcare Bullboards is StageZero Life Sciences Ltd. (TSX: SZLS, Forum) who briefly touched $0.90 a share after launching its saliva-based polymerase chain reaction (PCR) medical test last week which is designed for easier collection of patient samples.

Many bullboarders are seeing a holding pattern here, with few traders willing to drop shares now, especially with SZLS’ Q3 earnings report around a month away. Some users also pointed out that demand for quality testing in certified labs is bound to increase, and StageZero is at the forefront of this movement."

https://stockhouse.com/opinion/buzz-on-the-bullboards/2020/10/15/buzz-on-bullboards-who-s-who-business-covid
<< Previous
Bullboard Posts
Next >>